Literature DB >> 10587087

Localization of GABA(B) (R1) receptors in the rat hippocampus by immunocytochemistry and high resolution autoradiography, with specific reference to its localization in identified hippocampal interneuron subpopulations.

R S Sloviter1, L Ali-Akbarian, R C Elliott, B J Bowery, N G Bowery.   

Abstract

Immunocytochemical and autoradiographic methods were used to localize the GABA(B) receptor in the normal rat hippocampus. GABA(B) receptor 1-like immunoreactivity (GBR1-LI) was most intense in presumed GABAergic interneurons of all hippocampal subregions. It was also present throughout the hippocampal neuropil, where it was most intense in the dendritic strata of the dentate gyrus, which are innervated by the perforant pathway and inhibitory dentate hilar cells, and in strata oriens and radiatum of area CA3. The dendritic regions of area CA1 exhibited less GBR1-LI than area CA3. GBR1-LI was detectable in the somata of CA1 pyramidal cells, but was minimal or undetectable within the somata of dentate granule cells and CA3 pyramidal cells. GBR1-LI was similarly minimal in the dentate hilar neuropil, and in stratum lucidum, the two regions that contain granule cell axons and terminals. Nor was GBR1-LI detectable in the inhibitory basket cell fiber systems that surround hippocampal principal cell somata. Fluorescence co-localization studies indicated that significant proportions of interneurons expressing somatostatin, neuropeptide Y, cholecystokinin, calbindin, or calretinin also expressed GBR1-LI constitutively. Conversely, parvalbumin-positive GABAergic basket cells of the dentate gyrus and hippocampus, which form GABA(A) receptor-mediated inhibitory axo-somatic synapses, rarely contained detectable GBR1-LI. High resolution autoradiography with the GABA(B) receptor antagonist CGP 62349 revealed a close correspondence between receptor ligand binding and GBR1-LI, with several notable exceptions. Ligand binding closely matched GBR1-LI throughout the hippocampal, cortical, thalamic, and cerebellar neuropil. However, the hippocampal interneuron somata and dendrites that exhibited the most intense GBR1-LI, and the GBR1-positive somata of CA1 pyramidal cells, did not exhibit a similar density of [3H]-CGP 62349 binding. These data clarify the relationship between immunocytochemically identified receptor protein and potentially functional receptors, indicating that GBR1-LI reflects both non-functional cytoplasmic GBR1 and the ligand-bindable form of the protein, both before dimerization with GBR2 and after translocation to functional sites within cells. The staining and binding patterns further suggest that GBR1 is constitutively expressed in specific neuronal populations, and may exist in higher concentration in the axons of inhibitory hippocampal pathways that innervate dendritic zones, than in axo-somatic inhibitory terminals. Whether GBR1 is inducible in cells that contain GBR1 mRNA, but no detectable constitutive protein, remains to be determined in experimental studies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10587087     DOI: 10.1016/s0028-3908(99)00132-x

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  22 in total

1.  Regulation of hippocampal cannabinoid CB1 receptor actions by adenosine A1 receptors and chronic caffeine administration: implications for the effects of Δ9-tetrahydrocannabinol on spatial memory.

Authors:  Vasco C Sousa; Natália Assaife-Lopes; Joaquim A Ribeiro; Judith A Pratt; Ros R Brett; Ana M Sebastião
Journal:  Neuropsychopharmacology       Date:  2010-10-06       Impact factor: 7.853

2.  GABA(B) receptor GTP-binding is decreased in the prefrontal cortex but not the hippocampus of aged rats.

Authors:  Joseph A McQuail; Cristina Bañuelos; Candi L LaSarge; Michelle M Nicolle; Jennifer L Bizon
Journal:  Neurobiol Aging       Date:  2011-12-14       Impact factor: 4.673

3.  Functional Reduction in Cannabinoid-Sensitive Heterotypic Inhibition of Dentate Basket Cells in Epilepsy: Impact on Network Rhythms.

Authors:  Jiandong Yu; Archana Proddutur; Bogumila Swietek; Fatima S Elgammal; Vijayalakshmi Santhakumar
Journal:  Cereb Cortex       Date:  2015-09-22       Impact factor: 5.357

4.  A novel subpopulation of 5-HT type 3A receptor subunit immunoreactive interneurons in the rat basolateral amygdala.

Authors:  F Mascagni; A J McDonald
Journal:  Neuroscience       Date:  2006-12-05       Impact factor: 3.590

5.  Postsynaptic origin of CB1-dependent tonic inhibition of GABA release at cholecystokinin-positive basket cell to pyramidal cell synapses in the CA1 region of the rat hippocampus.

Authors:  Axel Neu; Csaba Földy; Ivan Soltesz
Journal:  J Physiol       Date:  2006-10-19       Impact factor: 5.182

6.  The GABAA receptor-mediated recurrent inhibition in ventral compared with dorsal CA1 hippocampal region is weaker, decays faster and lasts less.

Authors:  Theodoros Petrides; Panagiotis Georgopoulos; George Kostopoulos; Costas Papatheodoropoulos
Journal:  Exp Brain Res       Date:  2007-03       Impact factor: 1.972

7.  Neuronal localization of 5-HT type 2A receptor immunoreactivity in the rat basolateral amygdala.

Authors:  A J McDonald; F Mascagni
Journal:  Neuroscience       Date:  2007-02-28       Impact factor: 3.590

8.  GABAb Receptor Mediates Opposing Adaptations of GABA Release From Two Types of Prefrontal Interneurons After Observational Fear.

Authors:  Lei Liu; Wataru Ito; Alexei Morozov
Journal:  Neuropsychopharmacology       Date:  2016-12-07       Impact factor: 7.853

9.  STEP regulation of seizure thresholds in the hippocampus.

Authors:  Stephen W Briggs; Jeffrey Walker; Kemal Asik; Paul Lombroso; Janice Naegele; Gloster Aaron
Journal:  Epilepsia       Date:  2011-01-04       Impact factor: 5.864

10.  Redistribution of GABAB(1) protein and atypical GABAB responses in GABAB(2)-deficient mice.

Authors:  Martin Gassmann; Hamdy Shaban; Réjan Vigot; Gilles Sansig; Corinne Haller; Samuel Barbieri; Yann Humeau; Valérie Schuler; Matthias Müller; Bernd Kinzel; Klaus Klebs; Markus Schmutz; Wolfgang Froestl; Jakob Heid; Peter H Kelly; Clive Gentry; Anne-Lise Jaton; Herman Van der Putten; Cédric Mombereau; Lucas Lecourtier; Johannes Mosbacher; John F Cryan; Jean-Marc Fritschy; Andreas Lüthi; Klemens Kaupmann; Bernhard Bettler
Journal:  J Neurosci       Date:  2004-07-07       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.